|
NEW ORDER IN NOVO'S LARGEST DANISH INVESTMENT
04 September 2000 - NNE A/S
| NNE and GEA Liquid Processing Scandinavia A/S have formed a consortium which will carry out specific assignments for Novo Nordisk A/S in connection with its new Insulin Bulk Plant in Kalundborg. The contract establishing the new consortium, which will bear the name 'GEANNE I/S', was signed on Wednesday 13 September 2000 by the finance director of GEA, Morten Johansen, and the corporate manager of NNE, Hans Ole Voigt. |
NNE and GEA Liquid Processing Scandinavia A/S have formed a consortium which will carry out specific assignments for Novo Nordisk A/S in connection with its new Insulin Bulk Plant in Kalundborg. The contract establishing the new consortium, which will bear the name 'GEANNE I/S', was signed on Wednesday 13 September 2000 by the finance director of GEA, Morten Johansen, and the corporate manager of NNE, Hans Ole Voigt. In what is Novo Nordisk's largest Danish project to date, GEANNE I/S will be responsible for planning and setting up the CIP system of the production plant. The project has a value in excess of DKK 10 million and is expected to be completed in the autumn of 2001.
http://nne.dk/
About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field. Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely. NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France. |
More News:
• For September 2000
• From NNE A/S
• For Medical Equipment
|
